avrg: GSE58827: Dynamics of the Mouse Liver
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Sox2 | mm10_v2_chr3_+_34649987_34650005 | 0.40 | 1.7e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr5_-_134915512 Show fit | 25.47 |
ENSMUST00000008987.4
|
claudin 13 |
|
chr10_+_43579161 Show fit | 23.12 |
ENSMUST00000058714.8
|
CD24a antigen |
|
chr7_+_45216671 Show fit | 21.50 |
ENSMUST00000134420.1
|
TEA domain family member 2 |
|
chr4_+_115057683 Show fit | 21.44 |
ENSMUST00000161601.1
|
T cell acute lymphocytic leukemia 1 |
|
chr7_-_142661305 Show fit | 18.19 |
ENSMUST00000105936.1
|
insulin-like growth factor 2 |
|
chr11_+_116531097 Show fit | 15.02 |
ENSMUST00000138840.1
|
sphingosine kinase 1 |
|
chr16_-_36367623 Show fit | 13.41 |
ENSMUST00000096089.2
|
cDNA sequence BC100530 |
|
chr16_-_17125106 Show fit | 12.91 |
ENSMUST00000093336.6
|
RIKEN cDNA 2610318N02 gene |
|
chr3_-_98859774 Show fit | 12.51 |
ENSMUST00000107016.3
ENSMUST00000149768.1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
|
chr3_-_98859753 Show fit | 11.87 |
ENSMUST00000029465.6
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.7 | 32.0 | GO:0060217 | hemangioblast cell differentiation(GO:0060217) |
1.1 | 30.3 | GO:0048368 | lateral mesoderm development(GO:0048368) |
7.7 | 23.1 | GO:0002842 | positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
0.4 | 21.0 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
1.1 | 18.4 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
2.3 | 18.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.8 | 18.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
1.4 | 17.1 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
2.0 | 16.1 | GO:0015671 | oxygen transport(GO:0015671) |
1.3 | 16.1 | GO:0021778 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 35.9 | GO:0005923 | bicellular tight junction(GO:0005923) |
10.7 | 32.0 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
9.8 | 29.5 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
1.2 | 26.5 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 24.0 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 21.1 | GO:0005667 | transcription factor complex(GO:0005667) |
1.1 | 18.8 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.2 | 17.2 | GO:0016363 | nuclear matrix(GO:0016363) |
1.1 | 16.9 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 16.5 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 36.8 | GO:0070888 | E-box binding(GO:0070888) |
1.7 | 33.7 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
3.0 | 24.4 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
1.3 | 21.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.6 | 19.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
1.5 | 19.7 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 19.7 | GO:0003779 | actin binding(GO:0003779) |
0.5 | 17.4 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
2.8 | 16.9 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.5 | 16.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 30.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.3 | 23.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.4 | 21.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 21.0 | PID NOTCH PATHWAY | Notch signaling pathway |
0.4 | 17.3 | PID ATR PATHWAY | ATR signaling pathway |
0.6 | 15.4 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.3 | 14.5 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 12.4 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 11.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.3 | 10.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 28.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.3 | 25.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.6 | 24.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
1.9 | 24.4 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
1.2 | 19.7 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.6 | 19.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.9 | 18.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.4 | 17.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.4 | 16.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
1.0 | 16.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |